Skip to main content
Caplight Logo









Vivance

Vivance

Private
SingaporeHealthcare & Life Scienceshttps://vivance.com/

Last Round

Series B

Sep 13, 2023

Total Funding Raised

$60M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Vivance is a healthcare technology company that develops ultraportable dialysis devices and digital solutions for chronic kidney disease management.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

wearable dialysiswearable artificial kidneyhome dialysisportable dialysiskidney failuresorbent technologyend-stage renal diseaseESRDmedtechkidney carerenal careautomated peritoneal dialysisAPDremote patient monitoringRPMmedical AIFDA breakthrough devicehealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vivance Comparables

Compare Vivance with similar companies based on industry and business-model similarity.

Vivance comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Byonyks
83%
Diality
81%
Triomed AB
79%

Vivance Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 13, 2023
Series ADec 12, 2019
VC RoundDec 1, 2016

Key People

Founding team and executive leadership

Suresha Venkataraya

Chief Executive Officer

Executive Team

Vivance Investors

Notable investors and investment history

Vivance investors
InvestorRounds
EckuitySeries B
SEEDS CapitalSeries A
Lion X FundSeries B
Vickers Venture PartnersSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 734% MoM, reaching 1.2K.

  • Sep 13, 2023

    $20M round led by Lion X Fund and Vickers Venture Partners.

Vivance Filings

Explore SEC and related filing metadata, where available.

Vivance filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vivance's valuation, stock price, and market status.

Is Vivance a public or private company?

Vivance is a private company.

What is the current stock price of Vivance?

Vivance is a private company with no public stock price. No recent secondary market data is available.

How much is Vivance worth (valuation)?

Valuation information for Vivance is not publicly available.

Can I buy Vivance stock?

Vivance shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vivance's last funding round?

Vivance's most recent funding round was Series B on September 13, 2023.

Who are the main investors in Vivance?

Key investors in Vivance include Lion X Fund, Vickers Venture Partners.

Will Vivance IPO soon?

No public IPO plans have been announced for Vivance.

How can I track Vivance secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vivance's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range58
Year Founded2007
Last FundingSep 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?